Rudi Rossau

This inventor holds 35 USPTO granted patents, plus 2 CIPO patents and 8 EPO patents, primarily in Molecular Diagnostics. Top assignees: Innogenetics N.v., N.v. Innogenetics S.a., Enterprise Ireland. Active years: 1996-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rudi Rossau. Retrieved from https://idiyas.com/inventor/rudi-rossau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35

% Patents Active = 54.3

CIPO Patents = 2

EPO Patents = 8 (Patent Applications = 4)

Average Co-Inventor Count = 3.1

ph-index = 8

Forward Citations = 379(Granted Patents)

Location History:

Ekeren-Antwerpen, BE (1998)
Ekeran, BE (2004)
Ekeren, BE (1996 - 2014)

Company Filing History:

N.v. Innogenetics S.a.

Fujirebio Europe N.v.

where one patent can have more than one assignee

Years Active: 1996-2014

Loading Chart...

Areas of Expertise:

HBV Typing

HCV Detection

Antibiotic Resistance

Nucleic Acid Probes

Mycobacterium Detection

Hybridization Assays

16S-23S rRNA

RNA Probes

Isothermal PCR

Fungal Pathogen Detection

HLA Alleles

Eubacterial Differentiation

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8859203 - Method for typing and detecting HBV (2014-10-14),

2. 8835106 - Method for typing and detecting HBV (2014-09-16),

3. 8426129 - Method for typing HLA alleles (2013-04-23),

4. 8101351 - Process for typing of HCV isolates (2012-01-24),

5. 7741461 - Nucleic acid probes and methods for detecting clinically important fungal pathogens (2010-06-22),

6. 7390623 - [object Object] (2008-06-24),

7. 7313357 - Method for typing and detecting HBV (2007-12-25),

8. 7258982 - Process for typing of HCV isolates (2007-08-21),

9. 7258977 - Process for typing of HCV isolates (2007-08-21),

10. 7252936 - Method for the detection of the antibiotic resistance spectrum of Mycobacterium species (2007-08-07),

11. 6891026 - Process for typing of HCV isolates (2005-05-10),

12. 6887985 - Process for typing of HCV isolates (2005-05-03),

13. 6858387 - Nucleic acid probes and methods for detecting clinically important fungal pathogens (2005-02-22),

14. 6811978 - Detection and identification of pseudomonas species using the 16S-23S rRNA spacer (2004-11-02),

15. 6713251 - Method for detection of drug-induced mutations in the reverse transcriptase gene (2004-03-30),

Title: Innovations in Hepatitis B Detection: The Contributions of Rudi Rossau

Introduction: Rudi Rossau, a prominent inventor based in Ekeren, Belgium, has made significant contributions to the field of medical diagnostics with an impressive portfolio of 35 patents. His work focuses on innovative methods for the detection and genetic analysis of Hepatitis B Virus (HBV), showcasing his dedication to advancing healthcare technologies.

Latest Patents: Among Rudi Rossau's recent patents is a groundbreaking method for typing and detecting HBV. This invention involves a sophisticated technique for detecting and analyzing the genetic material of HBV in biological samples. The method utilizes a combination of at least two nucleotide probes that specifically hybridize to various mutant target sequences within critical regions of the HBV genome, including the RT pol gene, preCore region, and HBsAg region. The process allows for accurate inference of the HBV genotype and the identification of any present mutants based on the differential hybridization signals obtained. Furthermore, the patent includes sets of nucleotide probes and primers, enhancing the reliability and efficiency of assays used for HBV detection.

Career Highlights: Rudi Rossau's career has been marked by his roles in reputable companies such as Innogenetics N.V. and N.V. Innogenetics S.A., where he has applied his expertise to develop advanced diagnostic solutions. His dedication to innovation has positioned him as a key player in the medical field, particularly in viral detection.

Collaborations: Throughout his career, Rudi has collaborated with notable professionals in the industry, including Hugo Van Heuverswyn and Lieven Jozef Stuyver. These collaborations have helped foster a rich environment of innovation, contributing to the success of projects aimed at improving medical diagnostics.

Conclusion: Rudi Rossau’s contributions to the field of HBV detection through his innovative patents and collaborations highlight the importance of research and development in advancing healthcare solutions. His ongoing commitment to the development of effective diagnostic methods continues to pave the way for improved patient outcomes and enhanced understanding of viral diseases.

Profile summary based on public USPTO records.